TY - JOUR
KW - Humans
KW - *Warfarin/adverse effects/administration & dosage
KW - *Sulfonylurea Compounds/adverse effects
KW - *Drug Interactions
KW - *Hypoglycemia/chemically induced/epidemiology
KW - Female
KW - Male
KW - Aged
KW - Middle Aged
KW - *Anticoagulants/adverse effects/administration & dosage
KW - *Hypoglycemic Agents/adverse effects/administration & dosage
KW - Pharmacoepidemiology/methods
KW - United Kingdom/epidemiology
KW - Research Design
KW - Databases, Factual
KW - Aged, 80 and over
KW - Proportional Hazards Models
KW - propensity score
KW - cohort
KW - drug–drug interaction
KW - hypoglycemia
KW - prevalent new‐user
AU - W. Wang
AU - Y. Cui
AU - O. H. Y. Yu
AU - S. Suissa
AU - A. Douros
AD - Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Quebec, Canada.
Division of Endocrinology and Metabolism, Jewish General Hospital/McGill University, Montreal, Quebec, Canada.
Department of Medicine, McGill University, Montreal, Quebec, Canada.
Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
AN - 39375929
BT - Pharmacoepidemiol Drug Saf
DO - 10.1002/pds.70014
DP - NLM
ET - 2024/10/08
LA - eng
M1 - 10
N1 - 1099-1557
Wang, Wanqi
Cui, Ying
Yu, Oriana Hoi Yun
Suissa, Samy
Orcid: 0000-0002-1281-5296
Douros, Antonios
Orcid: 0000-0002-6005-4006
PJT-165882/CAPMC/CIHR/Canada
Journal Article
England
Pharmacoepidemiol Drug Saf. 2024 Oct;33(10):e70014. doi: 10.1002/pds.70014.
PY - 2024
SN - 1053-8569
EP - e70014
T2 - Pharmacoepidemiol Drug Saf
TI - The Prevalent New-User Design to Study Drug-Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia
VL - 33
ER -